ELAB
PMGC Holdings Inc.NASDAQHealthcare$5.72-32.87%ClosedMarket Cap: $101,107
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.01
P/S
0.12
EV/EBITDA
0.35
DCF Value
$-8,186.76
FCF Yield
-8742.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
31.4%
Operating Margin
-1318.6%
Net Margin
0.0%
ROE
0.0%
ROA
0.0%
ROIC
0.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $304.1K | 52.0% | $-3.4M | $4.7M | $397.68 | — |
| FY 2025 | $590.1K | 31.4% | $-7.8M | $0.00 | $0.00 | — |
| Q3 2025 | $285.9K | 14.9% | $-2.2M | $-2.6M | $-117.84 | — |
| Q2 2025 | $0.00 | -Infinity% | $-1.0M | $-562.4K | $-37.92 | — |
| Q1 2025 | $0.00 | -Infinity% | $-1.2M | $-1.6M | $-241.92 | — |
| Q4 2024 | $-1.7M | 100.0% | $352.5K | $-1.9M | $-3,219.60 | — |
| FY 2024 | $2.5M | 72.8% | $-1.9M | $-6.2M | $-6,592.32 | — |
| Q3 2024 | $527.5K | 74.7% | $-919.0K | $-1.5M | $-7,996.80 | — |
| Q2 2024 | $605.5K | 72.5% | $-1.4M | $-1.4M | $-9,077.76 | — |
| Q1 2024 | $614.6K | -2.9% | $-798.2K | $-1.4M | $-9,477.60 | — |
| Q4 2023 | $698.6K | 66.1% | $-1.1M | $-1.2M | $-7,858.08 | — |
| FY 2023 | $1.7M | 66.2% | $-3.8M | $-4.3M | $-47,072.64 | — |